Yahoo! Canada Finance: Medical Instruments & Supplies Industry News

Inverness Medical Innovations Extends Cardiology Products Distribution Agreement with Thermo Fisher Scientific

Thu, 24 Jul 2008 21:51:57 GMT

PRNewswire - Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets today announced that it had reached an agreement with Thermo Fisher Scientific to extend their cardiology products distribution relationship by two years through December 2010.

Harvard Bioscience, Inc. Schedules Second Quarter 2008 Conference Call for August 11, 2008

Thu, 24 Jul 2008 16:12:29 GMT

Business Wire - Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the second quarter ended June 30, 2008 after market trading hours on Monday, August 11, 2008.

Barielle Nails National Distribution for Exclusive Products at CVS/pharmacy

Thu, 24 Jul 2008 15:43:46 GMT

PRNewswire - Leading nail, hand and foot care company Barielle announces that select products will now be available exclusively at CVS/pharmacy locations nationwide.

Instrumentation Laboratory Announces Contract for Multi-Parameter Testing Products with Broadlane

Thu, 24 Jul 2008 14:59:41 GMT

PRNewswire - Instrumentation Laboratory (IL) today announced that Broadlane, Inc., a leading supply chain services company, has awarded the Company with a five-year contract covering its critical care products and services.

Apriso to Moderate MES Panel Discussion

Thu, 24 Jul 2008 14:57:24 GMT

Business Wire - Apriso Corporation:

New Computer Assisted Diagnostic Tests for Ovarian Cancer, Cervical Cancer and Endometrial Cancer to Be Jointly Developed by Health Discovery Corporat

Thu, 24 Jul 2008 14:43:40 GMT

Business Wire - Health Discovery Corporation (OTCBB: HDVY), a leader in support vector machine (SVM) based molecular diagnostics, and DCL Medical Laboratories, LLC, Indianapolis, IN, a full-service, clinical reference laboratory, today announced the signing of a Development and License Agreement for the collaborative development and commercialization of SVM-based computer assisted diagnostic (CAD) tests for the independent detection of ovarian, cervical and endometrial cancers.

BioPharm America Unveils Conference Program

Thu, 24 Jul 2008 13:54:31 GMT

Business Wire - With only two months until the start of BioPharm America™ in Atlanta, September 9-10, 2008, EBD Group today announced the conference’s program highlights covering a wide selection of important industry topics.

Sirona Dental Systems, Inc. Fiscal 2008 Third Quarter Earnings Release Scheduled for August 6th

Thu, 24 Jul 2008 13:30:44 GMT

Business Wire - Sirona (Nasdaq: SIRO), one of the leading global manufacturers of high-quality dental equipment and technologies, today announced that it will release its financial results for the quarter ended June 30, 2008 on Wednesday, August 6th, 2008 before the market opens and hold its conference call later that morning, commencing at 9:00 a.m.

Safeguard Scientifics to Release Second Quarter 2008 Financial Results on Thursday, August 7th

Thu, 24 Jul 2008 13:01:28 GMT

Business Wire - Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage technology and life sciences companies, today announced that it will release its financial results for the second quarter and six-months ended June 30, 2008 prior to market open on Thursday, August 7, 2008.

Supplemental New Drug Application for RISPERDAL(R) CONSTA(R) Submitted to the FDA for the Treatment of Bipolar Disorder

Thu, 24 Jul 2008 12:35:29 GMT

Business Wire - Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), submitted a supplemental New Drug Application (sNDA) for RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] to the U.S.

Philips Introduces HD15 Ultrasound System

Thu, 24 Jul 2008 12:33:19 GMT

Business Wire - Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the latest addition to its HD ultrasound family of products.

NuPathe Inc. Completes $30 Million Series B Financing

Thu, 24 Jul 2008 12:31:35 GMT

Business Wire - NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced that the company has raised $30 million in a recently completed Series B equity financing.

Functional Technologies Acquires Product Development and Laboratory Facility

Thu, 24 Jul 2008 12:30:36 GMT

Marketwire - Functional Technologies Corp. (TSX VENTURE:FEB) is pleased to announce the purchase of a product development and laboratory facility in Prince Edward Island (PEI).

RTI Biologics Announces 2008 Second Quarter Results

Thu, 24 Jul 2008 12:23:52 GMT

Business Wire - RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the quarter ended June 30, 2008 as follows:

IntriCon Reports 2008 Second-Quarter Results

Thu, 24 Jul 2008 12:11:50 GMT

Business Wire - IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced financial results for its 2008 second quarter ended June 30, 2008.

BioSante Featured on TheStreet.com TV

Thu, 24 Jul 2008 12:07:46 GMT

Business Wire - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announces that its CEO, Stephen M. Simes,...

Aspect Medical Systems, Inc. Reports Operating Results for Second Quarter Ended June 28, 2008

Thu, 24 Jul 2008 11:55:46 GMT

Business Wire - Aspect Medical Systems, Inc. (NASDAQ: ASPM), reported today that product revenue was $25.2 million for Q2 2008, a 9% increase from $23.1 million in Q2 2007, and that total revenue was $25.2 million for Q2 2008, a 5% decline from $26.6 million in Q2 2007.

Laboratory Corporation of America(R) Holdings Announces 2008 Second Quarter Results

Thu, 24 Jul 2008 11:55:24 GMT

Business Wire - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended June 30, 2008.

Aspect Medical Systems' Letter to the Editor Regarding Anesthesia Awareness Study Published in New England Journal of Medicine

Thu, 24 Jul 2008 11:42:22 GMT

Business Wire - Aspect Medical Systems (NASDAQ: ASPM), the global market leader in brain monitoring technology, today announced that the Company’s letter to the editor regarding a study and editorial evaluating use of BIS® technology to reduce the risk of anesthesia awareness was published in the July 24th issue of the New England Journal of Medicine (NEJM).

Celgene Reports Record Second Quarter 2008 Product Sales and Operating Profits

Thu, 24 Jul 2008 11:34:12 GMT

Business Wire -

Medical Action Industries 1st Quarter Earnings Call to Take Place on August 7, 2008

Thu, 24 Jul 2008 11:30:40 GMT

Business Wire - Medical Action Industries Inc. (NASDAQ/MDCI), announced today that it will hold a conference call to present financial results for the quarter ended June 30, 2008 on Thursday, August 7, 2008 at 10:00 a.m. (ET).

Investment Report of China Medical Industry, 2000-2008 Available Now

Thu, 24 Jul 2008 11:21:19 GMT

Business Wire - Research and Markets (http://www.researchandmarkets.com/resea rch/955ff7/investment_report) has announced the addition of the "Investment Report of China Medical Industry, 2000-2008" report to their offering.

GE Healthcare to Acquire Vital Signs, Inc., Expanding GE's Monitoring, Anesthesia and Respiratory Care Offerings

Thu, 24 Jul 2008 11:10:53 GMT

Business Wire - GE Healthcare, a unit of General Electric Company (NYSE:GE), and Vital Signs, Inc. (NASDAQ:VITL) announced today that they have entered into a definitive merger agreement for GE to acquire Vital Signs.

Cancer Treatment Application of the Aethlon Hemopurifier(R) Published in Journal of Translational Medicine

Thu, 24 Jul 2008 11:09:09 GMT

Business Wire - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine.

Invacare Corporation Reports Strong Second Quarter Results

Thu, 24 Jul 2008 11:08:06 GMT

Business Wire - Invacare Corporation (NYSE: IVC) today announced its financial results for the second quarter and six months ended June 30, 2008.

ZOLL Medical Corporation Announces Record Third Quarter Results

Thu, 24 Jul 2008 11:07:20 GMT

Business Wire - ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and software solutions, today announced revenues for the third quarter of fiscal 2008 of $100,244,000, an increase of 27% compared to revenues in the third quarter of last year.

Applied Biosystems Reports Financial Results for Fourth Quarter and Fiscal 2008

Thu, 24 Jul 2008 11:05:14 GMT

Business Wire - Applied Biosystems (NYSE: ABI) today reported net revenues of $609.0 million for the fourth quarter of fiscal 2008, an increase of approximately 9% over the prior year quarter of $557.3 million.

CONMED Corporation Announces Second Quarter 2008 Financial Results

Thu, 24 Jul 2008 11:00:43 GMT

Business Wire - CONMED Corporation (Nasdaq: CNMD) today announced that it had better than expected second quarter 2008 sales growth of 13.9% over the second quarter of 2007.

Kinetic Concepts Reports Second Quarter and First Half 2008 Financial Results

Thu, 24 Jul 2008 10:33:02 GMT

Business Wire - Kinetic Concepts, Inc. (NYSE:KCI) today reported second quarter 2008 total revenue of $462.1 million, an increase of 17% from the second quarter of 2007.

TheraGenetics Expands Research and Development Team with the Appointment of Two Industry Veterans

Thu, 24 Jul 2008 10:31:48 GMT

Business Wire - TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced today the appointment of two industry veterans to newly created positions: Susan E.

ArthroCare Announces Informal Inquiry by SEC

Thu, 24 Jul 2008 10:03:31 GMT

Business Wire - ArthroCare Corp. (NASDAQ: ARTC) announced today that it has been informed by the SEC’s Fort Worth District Office that the Staff of the SEC's Division of Enforcement is conducting an informal inquiry into accounting matters related to ArthroCare Corporation arising out of the Company's recently announced restatement of financial results.

Thermo Fisher Scientific Reports Record 2008 Second Quarter Results

Thu, 24 Jul 2008 09:01:59 GMT

Business Wire - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported that revenues increased 14% to a record $2.71 billion in the second quarter of 2008, over $2.39 billion in the 2007 quarter. Currency translation increased revenues by 4%, and acquisitions, net of divestitures, increased revenues by 2%.

Q-Med: Interim Report January - June 2008

Thu, 24 Jul 2008 08:40:13 GMT

Business Wire - Regulatory News:

Promising Opportunities for Cardiovascular Monitoring Equipment in Europe

Thu, 24 Jul 2008 07:28:18 GMT

Business Wire - Technologically advanced, cost-effective cardiovascular monitoring systems are increasingly in demand in Europe.

Spiration, Inc. Signs Agreement with Olympus Medical Systems for Development and Distribution Rights of Minimally Invasive Pulmonary Device Therapy in

Thu, 24 Jul 2008 02:00:26 GMT

Business Wire - Spiration, Inc., a developer of novel medical devices designed to benefit patients with severe and chronic conditions of the lung, announced today that it has signed a definitive agreement giving Olympus Medical Systems Corp. exclusive development and distribution rights in Japan for the IBV® Valve System.

Owens & Minor Announces Cash Dividend for Third Quarter 2008

Wed, 23 Jul 2008 22:31:38 GMT

Business Wire - Owens & Minor (NYSE:OMI) today announced that its board of directors has approved the payment of the third quarter 2008 cash dividend in the amount of $0.20 per share.

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

Wed, 23 Jul 2008 21:32:36 GMT

Business Wire - CHAD Therapeutics, Inc. (AMEX:CTU) today announced that on July 23, 2008, it received a letter from the American Stock Exchange ("AMEX") stating that the Company was not in compliance with Section 1003 of the AMEX Company Guide.

CORRECTING and REPLACING Quidel Reports Second Quarter 2008 Results

Wed, 23 Jul 2008 21:32:15 GMT

Business Wire - Conference call information, first U.S. dial-in number should read: 1-800-561-2601 (sted (888) 561-2601).

BioSphere Medical Reports 2008 Second Quarter Financial Results

Wed, 23 Jul 2008 20:26:49 GMT

Business Wire - BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere”) – a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported record total revenue for the second quarter of 2008 of $7.61 million, an increase of 9% compared with $6.97 million in the second quarter of 2007.

Conceptus Reports Sharply Higher Second Quarter Net Sales of $25.7 Million

Wed, 23 Jul 2008 20:19:52 GMT

Business Wire - Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first and only non-incisional permanent birth control method available, today reported financial results for the three and six months ended June 30, 2008.

Bard Announces Second Quarter Results

Wed, 23 Jul 2008 20:15:48 GMT

Business Wire - C. R. Bard, Inc. (NYSE: BCR) today reported 2008 second quarter financial results. Second...

Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine

Wed, 23 Jul 2008 20:15:03 GMT

Business Wire - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced an agreement with Novartis Vaccines and Diagnostics, Inc. for the supply and development, and possible commercialization, of Dynavax’s novel Universal Influenza Vaccine in collaboration with Novartis.

SurModics Reports Third Quarter 2008 Results

Wed, 23 Jul 2008 20:03:15 GMT

Business Wire - SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, today reported financial results for the third fiscal quarter ended June 30, 2008.

PSS World Medical Reports Results for Fiscal Year 2009 First Quarter

Wed, 23 Jul 2008 20:02:10 GMT

Business Wire - PSS World Medical, Inc. (NASDAQ GS:PSSI):

Quidel Reports Second Quarter 2008 Results

Wed, 23 Jul 2008 20:01:27 GMT

Business Wire - Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the quarter and six months ended June 30, 2008.

Bruker BioSpin's MRI CryoProbe(TM) Selected for 2008 R&D 100 Award for Enabling Preclinical MRI on Mice at 60 Micrometer Spatial Resolution

Wed, 23 Jul 2008 18:41:20 GMT

Business Wire - A prestigious 2008 R&D 100 Award has been given to Bruker BioSpin for the MRI CryoProbe™, as one of the 100 most technologically significant products introduced into the marketplace over the past year.

National Council on Aging and EyeCare America Join Forces To Help Medically Underserved Seniors Improve their Vision

Wed, 23 Jul 2008 17:16:09 GMT

Business Wire - The National Council on Aging (NCOA) and EyeCare America are working together to benefit older Americans with limited means who have vision or other eye problems. This means seniors can now determine whether they qualify for benefits programs related to eye care by visiting NCOA's BenefitsCheckUp® Web site.

Ron Ho Named President & CEO of U-Systems, Inc.

Wed, 23 Jul 2008 17:13:15 GMT

Business Wire - U-Systems, the innovative leader in dedicated breast ultrasound systems, has appointed Ron Ho as President & Chief Executive Officer.

QuantRx Biomedical Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography

Wed, 23 Jul 2008 16:00:24 GMT

Business Wire - QuantRx® Biomedical Corporation (OTCBB:QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that QuantRx’s FluoroPharma has achieved positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging.

UC Irvine Extension Offers Certificate Program in Project Management for Life Science Professionals

Wed, 23 Jul 2008 15:04:43 GMT

Business Wire - With more and more baby boomers reaching retirement age, America’s healthcare needs and the urgency for advanced medical devices has created an upsurge in demand for new pharmaceuticals and medical products.

Global Vascular Closure Device Market to Exceed $900 Million by 2013

Wed, 23 Jul 2008 14:36:32 GMT

Business Wire - According to a new Life Science Intelligence (LSI) report, 2008 Global Vascular Closure Device Markets: U.S., Europe, Rest of World, the global market for vascular closure devices will reach nearly $1 billion in 2013.

TheraDoc(R) Real-Time Surveillance and Clinical Decision Support Technologies Adopted by Two Leading Health Systems

Wed, 23 Jul 2008 14:22:28 GMT

Business Wire - BayCare Health System in the Tampa Bay region and PeaceHealth healthcare system, headquartered in Bellevue, Wash., have selected real-time electronic surveillance and expert clinical decision support systems provided by TheraDoc, Inc., a clinical informatics company headquartered in Salt Lake City, UT. TheraDoc’s interoperable, patented Expert System Platform® (ESP) is a standards-based, scalable solution that provides hospitals with real-time surveillance, management, prevention and reporting of patient safety problems such as hospital-acquired infections (HAI) and adverse drug events (ADE).

Simulations Plus Subsidiary, Words+, Inc., Releases Major New Product

Wed, 23 Jul 2008 13:37:52 GMT

Business Wire - Words+, Inc., a wholly owned subsidiary of Simulations Plus, Inc. (NASDAQ: SLP), today announced the launch of a major new augmentative communication product called Conversa™. Words+, Inc. has been in business since September 1981 as one of the early pioneers in assistive technologies for those who experience various disabilities.

University of Iowa to Begin Using LUMA(R) Cervical Pre-Cancer Imaging Device

Wed, 23 Jul 2008 13:30:32 GMT

PRNewswire - SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego-based medical devices company, today announced that it has placed its LUMA Cervical Imaging System to detect pre-cancers at the University of Iowa in Iowa City, Iowa under the direction of Dr.

Pioneer Surgical Technology Hires Noted Sales Consultant

Wed, 23 Jul 2008 13:23:07 GMT

Business Wire - Pioneer Surgical Technology’s European subsidiary today announced that Karen McRae, RN, MN, a respected professional in the Spine Industry, has joined the growing sales team.